bf/NASDAQ:MRNS_icon.jpeg

NASDAQ:MRNS

Marinus Pharmaceuticals, Inc.

  • Stock

USD

Last Close

1.34

15/05 20:00

Market Cap

546.83M

Beta: 1.16

Volume Today

1.07M

Avg: 544.92K

PE Ratio

−4.02

PFCF: −4.81

Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
asset turnover
0.01
-
0.11
882.10%
0.10
12.45%
0.18
84.69%
cash conversion cycle
-2.99K
-
-6.63K
121.50%
-188.80
97.15%
cash per share
4.98
-
32.32
549.20%
15.07
53.39%
6.17
59.01%
9.07
46.92%
7.11
21.59%
6.73
5.42%
5.13
23.70%
3.35
34.74%
6.16
83.79%
2.80
54.58%
company equity multiplier
1.25
-
1.22
2.40%
1.27
4.21%
1.46
15.14%
1.05
28.56%
1.10
5.28%
1.13
2.27%
1.10
2.62%
2.56
133.29%
2.24
12.55%
10.19
355.67%
days of inventory outstanding
-2.30K
-
82.66
103.60%
354.42
328.76%
days of payables outstanding
771.98
-
6.81K
781.79%
587.97
91.36%
days of sales outstanding
349.70
-
75.78
78.33%
90.94
20.00%
44.75
50.80%
dividend yield
ebit per revenue
-39.54
-
-6.32
84.03%
-4.43
29.92%
-4.24
4.15%
ebt per ebit
0.98
-
0.91
7.24%
1.02
11.92%
1.01
0.29%
0.99
2.15%
0.99
0.46%
0.99
0.67%
0.99
0.13%
1.02
2.60%
0.15
85.71%
1.09
646.43%
effective tax rate
0.01
-
-0.12
2,389.18%
-0.02
84.41%
-0.01
26.03%
-0.00
95.06%
-0.01
1,693.07%
0.01
153.03%
0.01
88.74%
-0.03
336.51%
-0.21
606.59%
0.01
105.22%
enterprise value multiple
-10.54
-
-2.08
80.23%
-2.86
37.21%
0.04
101.54%
-8.46
19,284.16%
-1.36
83.97%
-0.50
62.89%
-2.87
469.41%
-3.68
28.36%
2.15
158.42%
-4.38
304.01%
fixed asset turnover
0.88
-
6.14
595.18%
6.01
2.05%
6.40
6.39%
free cash flow per share
-3.30
-
-5.61
70.04%
-5.49
2.04%
-5.21
5.05%
-3.27
37.21%
-2.73
16.57%
-3.60
31.69%
-2.23
37.90%
-1.59
28.79%
-2.93
84.51%
-2.20
25.11%
gross profit margin
1
-
0.90
9.63%
0.99
9.18%
0.92
6.77%
interest coverage
-59.36
-
-101.88
71.63%
-51.44
49.51%
-60.87
18.33%
-119.77
96.77%
-37.54
-
-10.57
71.85%
-7.78
26.36%
inventory turnover
-0.16
-
4.42
2,880.80%
1.03
76.68%
long term debt to capitalization
0.15
-
0.10
30.77%
0.08
25.41%
0.43
-
0.38
12.26%
0.85
123.90%
net income per ebt
1
-
1
0%
1
0%
1
0%
1
0%
1
0%
0.99
0.65%
0.99
0.58%
1.03
4.21%
1.21
17.21%
0.99
17.99%
net profit margin
-38.79
-
-6.62
82.92%
-0.78
88.26%
-4.56
486.69%
operating cash flow per share
-3.29
-
-5.58
69.83%
-5.40
3.35%
-5.08
5.84%
-3.20
37.08%
-2.72
14.82%
-3.57
31.04%
-2.23
37.41%
-1.51
32.32%
-2.89
91.11%
-2.20
24.01%
operating cycle
-2.22K
-
173.60
107.81%
399.17
129.93%
operating profit margin
-39.54
-
-6.32
84.03%
-4.43
29.92%
-4.24
4.15%
payables turnover
0.47
-
0.05
88.66%
0.62
1,057.76%
pretax profit margin
-39.28
-
-6.44
83.61%
-0.64
89.98%
-4.61
615.42%
price fair value
6.82
-
1.58
76.83%
2.43
53.73%
0.92
62.26%
3.31
261.18%
1.72
48.13%
1.34
21.90%
2.42
80.75%
8.15
236.14%
1.34
83.55%
34.85
2,499.43%
receivables turnover
1.04
-
4.82
361.45%
4.01
16.67%
8.16
103.24%
return on assets
-0.45
-
-0.22
51.59%
-0.42
93.06%
-0.91
118.68%
-0.31
65.80%
-0.49
56.72%
-0.54
11.43%
-0.44
18.58%
-0.74
67.73%
-0.08
89.72%
-0.83
983.56%
return on capital employed
-0.57
-
-0.25
56.49%
-0.47
89.06%
-1.21
158.41%
-0.33
72.90%
-0.54
66.10%
-0.60
10.13%
-0.49
18.87%
-1.01
107.08%
-0.55
45.26%
-1.01
83.11%
return on equity
-0.56
-
-0.26
52.76%
-0.53
101.20%
-1.33
151.79%
-0.33
75.57%
-0.54
64.99%
-0.61
13.97%
-0.49
20.71%
-1.90
291.30%
-0.17
91.01%
-8.43
4,837.46%
total debt to capitalization
0.15
-
0.14
6.53%
0.20
44.40%
0.01
-
0.00
26.75%
0.44
11,675.61%
0.39
11.68%
0.87
125.21%

All numbers in USD (except ratios and percentages)